Carlisle Companies Incorporated
Carlisle Companies Incorporated (CSL) Financial Performance & Income Statement Overview
Explore the financials of Carlisle Companies Incorporated (CSL), including yearly and quarterly data on income, cash flow, and balance sheets.
Carlisle Companies Incorporated (CSL) Income Statement & Financial Overview
Explore comprehensive income reports for Carlisle Companies Incorporated CSL, broken down by year and quarter.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $1.10B | $1.12B | $1.33B | $1.45B |
Cost of Revenue | $710.10M | $717.40M | $819.20M | $881.70M |
Gross Profit | $385.70M | $405.50M | $514.40M | $568.90M |
Gross Profit Ratio | $0.35 | $0.36 | $0.39 | $0.39 |
R&D Expenses | $10.70M | $8.80M | $8.10M | $9.00M |
SG&A Expenses | $194.00M | $67.00M | $191.80M | $162.10M |
Operating Expenses | $202.10M | $181.50M | $198.00M | $191.40M |
Total Costs & Expenses | $912.20M | $898.90M | $1.02B | $1.07B |
Interest Income | $6.40M | $16.00M | $22.60M | $13.80M |
Interest Expense | $14.80M | $17.30M | $18.60M | $18.80M |
Depreciation & Amortization | $47.80M | $46.00M | $44.60M | $43.10M |
EBITDA | $237.60M | $265.30M | $384.70M | $434.50M |
EBITDA Ratio | $0.22 | $0.24 | $0.29 | $0.30 |
Operating Income | $183.60M | $224.00M | $316.40M | $377.50M |
Operating Income Ratio | $0.17 | $0.20 | $0.24 | $0.26 |
Other Income/Expenses (Net) | -$8.60M | -$22.00M | $5.10M | -$4.90M |
Income Before Tax | $175.00M | $202.00M | $321.50M | $372.60M |
Income Before Tax Ratio | $0.16 | $0.18 | $0.24 | $0.26 |
Income Tax Expense | $34.90M | $39.60M | $74.90M | $87.40M |
Net Income | $143.30M | $162.80M | $244.30M | $712.40M |
Net Income Ratio | $0.13 | $0.14 | $0.18 | $0.49 |
EPS | $3.23 | $3.61 | $5.31 | $15.03 |
Diluted EPS | $3.20 | $3.57 | $5.25 | $14.84 |
Weighted Avg Shares Outstanding | $44.30M | $46.50M | $45.90M | $47.30M |
Weighted Avg Shares Outstanding (Diluted) | $44.70M | $47.10M | $46.50M | $47.90M |
Financial performance has remained strong, with revenue growing from $1.45B in Q2 2024 to $1.10B in Q1 2025. Gross profit continued to perform well, with margins at 35% in the latest quarter. Operating income reached $183.60M in Q1 2025, holding a steady 17% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $237.60M. Net income dropped to $143.30M, keeping EPS at $3.23. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan